XENE Price / Book | XENON PHARMACEUTICALS INC.

XENON PHARMACEUTICALS INC. (XENE) Price / Book

2026-09-03: Price/Book Ratio 4.71.
2026-06-30: Price/Book Ratio 4.7.
2026-03-31: Price/Book Ratio 4.2.
2025-12-31: Price/Book Ratio 6.16.

Historical market capitalization divided by filed shareholder equity.

Available history: 2014-12-31 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	4.71
2026-06-30	4.7
2026-03-31	4.2
2025-12-31	6.16
2025-09-30	5.53
2025-06-30	3.8
2025-03-31	3.65
2024-12-31	3.97
2024-09-30	3.74
2024-06-30	3.5
2024-03-31	3.66
2023-12-31	3.74
2023-09-30	3.49
2023-06-30	3.79
2023-03-31	3.29
2022-12-31	3.42
2022-09-30	3
2022-06-30	2.41
2022-03-31	2.99
2021-12-31	2.93
2021-09-30	2.54
2021-06-30	2.98
2021-03-31	2.65
2020-12-31	3.14
2020-09-30	2.13
2020-06-30	2.32
2020-03-31	2.11
2019-12-31	4.01
2019-09-30	3.13
2019-06-30	3.07
2019-03-31	2.84
2018-12-31	1.57
2018-09-30	2.99
2018-06-30	3.21
2018-03-31	2.44
2017-12-31	1.41
2017-09-30	1.23
2017-06-30	1.12
2017-03-31	1.26
2016-12-31	2.16
2016-09-30	2.09
2016-06-30	1.62
2016-03-31	1.73
2015-12-31	1.89
2015-09-30	1.84
2015-06-30	2.56
2015-03-31	3.48
2014-12-31	3.85

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Organon & Co. (OGN)	United States	$3.603B	17.03
ACADIA PHARMACEUTICALS INC (ACAD)	United States	$3.823B	11.45
IDEAYA Biosciences, Inc. (IDYA)	United States	$3.540B	-20.52
AbCellera Biologics Inc. (ABCL)		$3.879B	-14.59
Amylyx Pharmaceuticals, Inc. (AMLX)	United States	$3.361B	-13.15
Enliven Therapeutics, Inc. (ELVN)	United States	$3.307B	-35.07
Arcutis Biotherapeutics, Inc. (ARQT)	United States	$3.303B	115.47
Tango Therapeutics, Inc. (TNGX)	United States	$4.154B	-42.53
Arcus Biosciences, Inc. (RCUS)	United States	$3.188B	-8.52
Indivior Pharmaceuticals, Inc. (INDV)		$4.250B	14.09